Calcium channel blockers effective for pregnant patient with vasospastic angina: Case study Dr. Kamal Kant Kohli9 Dec 2023 4:30 AM ISTJapan: Treatment with a calcium channel blocker in a woman diagnosed with severe vasospastic angina (VSA) led her to carry a healthy baby to full term...
ACE inhibitors raise stroke outcomes risk by 11 per cent compared to diuretics: JAMA Medha Baranwal7 Dec 2023 11:15 AM ISTUSA: A recent study published in JAMA Network Open has shed light on the difference in the long-term risk of morbidity and mortality outcomes for...
Calcium channel blockers represent an important risk factor for glaucoma Dr Ishan Kataria20 Oct 2023 8:00 PM ISTCalcium channel blocker (CCB) use has been associated with an increased risk of glaucoma in exploratory studies. To examine the association of...
Calcium Channel Blocker Use Linked to Increased Glaucoma Risk Dr. Kamal Kant Kohli15 Sept 2023 8:00 PM ISTA recent study published in JAMA Ophthalmology by Alan Kastner and colleagues conducted using data from the UK Biobank has raised concerns about the...
Amlodipine as First-line Antihypertensive-Review of Indian Evidence Dr. Prem Aggarwal30 Jan 2023 12:00 PM ISTHypertension, often referred to as "the silent killer," is a significant global public health burden due to its risk for myocardial infarction (MI)...
When to Introduce time tested drug Amlodipine to manage Hypertension? dr. Abhimanyu Uppal6 May 2022 11:45 AM ISTAmlodipine: Is old still gold? Hypertension is one of the most important risk factors for cardiovascular disease. There exist more than three decades...
Hypertension complicating angina: Tackling the dual menace with amlodipine-atenolol combination dr. Abhimanyu Uppal27 Dec 2021 11:12 AM ISTEpidemiological studies have established a strong association between hypertension and coronary artery disease (CAD). (1) Hypertension is a major...
Combining ARBs, CCBs and Diuretics in controlling Resistant Hypertension in CV patients: Review Dr. Prem Aggarwal12 Nov 2021 12:57 PM ISTA significant increase in resistant hypertension (RH) has been documented in the last decade, with epidemiological data suggesting that the rise has...
Reviewing the triple A in cardiology: The role of amlodipine-atenolol in angina relief dr. Abhimanyu Uppal27 July 2021 12:45 PM ISTAmlodipine, a charged dihydropyridine-type (DHP) calcium channel blocker (CCB), has been widely used to treat hypertension. (1) Amlodipine...
BPLTTC: Using Antihypertensive agents as risk modifiers for prevention of CV events irrespective of baseline criteria: Scope of Amlodipine Dr. Prem Aggarwal13 Oct 2020 12:17 PM ISTHypertension, a prominent cause of premature mortality, affects ~1.13 billion people worldwide, though blood pressure (BP) control rates remain dismal...
Prompt BP Control with an Early Combination Therapy: Role of a Fixed-Dose Combination of an ARB and a CCB Dr Tiny Nair11 Sept 2020 10:48 AM ISTEarly start of a combination therapy provides prompt blood pressure control and is recommended by international guidelines as well. Renin-angiotensin...
JB Chemicals brings BP Lowering Drug, Azelnidipine (DHP CCB) to Indian market under brand name Azovas Meghna A Singhania20 Jun 2020 12:45 PM ISTNew Delhi: Known for its Calcium Channel Blockers (CCB) range for the management of hypertension, JB Chemicals and Pharmaceuticals Ltd has brought yet...
